Capsule availability is often a hidden bottleneck in
early clinical development. The new Capsugel® CapsuleCaddy® programs, available for customers located in EMEA, removes that barrier, giving you immediate access to GMP capsules in clinically relevant quantities, so you can move from formulation to first-in-human faster.